ecancermedicalscience

Erratum

METNET: a phase II trial of metformin in patients with well-differentiated neuroendocrine tumours

4 Jul 2022
João Glasberg, Aley Talans, Thomás Rivelli Giollo, Débora Zachello Recchimuzzi, João Evangelista Bezerra Neto, Rossana Veronica Mendonza Lopez, Paulo Marcelo Gehm Hoff, Rachel P Riechelmann

Thomás Rivelli Giollo is corrected to Thomás Giollo Rivelli

Related Articles

Neha Singh, Sujata Agrawal, Zachariah Chowdhury, Shashikant Patne, Ipsita Dhal, Paramita Paul, Sadaf Haiyat, Akhil Kapoor, Anuj Gupta, Bal Krishna Mishra, Mayank Tripathi, Bipinesh Sansar
Paulina B Crespo-Morfin, Rodrigo Figueroa-Mendez, Eleazar Ignacio-Álvarez, Miguel A Ávila-Rodríguez, Alfredo A Reza-Albarrán
Ariel Cherro, Laura Aresca, María Susana Ciruzzi, Alejo Agranatti, María Fernanda Montaña, Cynthia Frahne, Jaqueline Cimerman
Nishu Dhingra, Dama Swetha, Pariseema S Dave, Bijal M Patel, Chetna Parekh, Ruchi Arora
Agnes Chipo Tererai, Margaret Borok, Zvavahera Mike Chirenje, Liz Gwyther, Lindsay Farrant, Ntokozo Ndlovu, Simbarashe Rusakaniko